Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: GeneDx Holdings Corp., 3 years.
GeneDx Holdings Corp.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | GeneDx Holdings Corp. | Option exercise | +3,576 | — | — |
| Aug 27, 2025 | GeneDx Holdings Corp. | Open-market sale | −8,818 | $125.07 | $1,102,867 |
| Aug 27, 2025 | GeneDx Holdings Corp. | Open-market sale | −8,969 | $126.15 | $1,131,439 |
| Aug 27, 2025 | GeneDx Holdings Corp. | Open-market sale | −5,443 | $127.44 | $693,656 |
| Aug 27, 2025 | GeneDx Holdings Corp. | Open-market sale | −3,452 | $128.04 | $441,994 |
| Aug 27, 2025 | GeneDx Holdings Corp. | Open-market sale | −9,890 | $129.59 | $1,281,645 |
| Aug 27, 2025 | GeneDx Holdings Corp. | Open-market sale | −1,500 | $130.01 | $195,015 |
| Aug 27, 2025 | GeneDx Holdings Corp. | Open-market sale | −1,150 | $129.65 | $149,098 |
| Jun 18, 2025 | GeneDx Holdings Corp. | Option exercise | +12,924 | — | — |
| Nov 20, 2024 | GeneDx Holdings Corp. | Open-market sale | −9,361 | $68.36 | $639,918 |
| Nov 20, 2024 | GeneDx Holdings Corp. | Open-market sale | −1,857 | $69.84 | $129,693 |
| Nov 20, 2024 | GeneDx Holdings Corp. | Open-market sale | −4,272 | $70.50 | $301,176 |
| Nov 19, 2024 | GeneDx Holdings Corp. | Gift | −141,356 | — | — |
| Nov 19, 2024 | GeneDx Holdings Corp. | Open-market sale | −5,952 | $70.86 | $421,759 |
| Nov 19, 2024 | GeneDx Holdings Corp. | Open-market sale | −24,784 | $71.35 | $1,768,338 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.